Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC

Abstract Background Stereotactic ablative radiotherapy (SABR) is thought to activate T cell responses in patients with cancer, leading to its combination with immunotherapy and chemotherapy for treatment of non-small-cell lung cancer (NSCLC). Here, we aimed to provide a high-resolution transcriptomi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chao Liu, Yanjuan Chen, Xiaohui Li, Zhijie Bai, Meilin Jiang, Dongsheng Sheng, Wenxue Zou, Rui Huang, Qingyu Huang, Fuhao Wang, Jingyang Zhu, Huiru Sun, Bing Liu, Zongcheng Li, Bing Sun
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2025-02-01
Col·lecció:	Cancer Immunology, Immunotherapy
Matèries:	SABR Non-small-cell lung cancer Immunotherapy Single-cell RNA sequencing Immune response
Accés en línia:	https://doi.org/10.1007/s00262-024-03935-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!